Skip to main content
Erschienen in: Obesity Surgery 11/2020

03.07.2020 | Original Contributions

Insurance-Related Delay in Access to Bariatric Surgery, Is It Helpful as Is Thought?

verfasst von: Emiliano Domeniconi, Carlos Martin Esquivel, Manuel Garcia, Matias Sosa, Pablo Arias, Fernando Martínez Lascano, José María Foscarini

Erschienen in: Obesity Surgery | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

In Argentina, health insurances demand a 24-month duration preoperative weight loss program (POWLP) before bariatric surgery. It is unknown whether it enhances weight loss before or after surgery, or even if it is related to comorbidity remission. The main objective of this study was to determine its effectiveness and reliability.

Methods

An observational, longitudinal, retrospective study was carried out from June 2009 to December 2016, enrolling patients who underwent bariatric surgery in Sanatorio Allende Hospital of Cordoba, Argentina. Patients were divided into three groups according time-to-surgery from preoperative assessment initiation (A = before the 6th month, B = from 6th to 24th month, and C = over 24th month; all related to the first visit as previously mentioned). BMI, %EWL, comorbidity remission BMI, %EWL, comorbidity remission, and complications rate were assessed after surgery at 1, 3, 6, 12 months, and then annually until the 5th postoperative year. Revisional surgeries were excluded.

Results

Three hundred seventy-six patients were recruited. There were no significant differences in the preoperative and postoperative weight loss, neither co-morbidities resolution between groups.

Conclusions

Insurance-related delay in access to bariatric surgery is not associated to any benefit in comorbidity remission, as well as any improvement in weight loss in all groups studied.
Literatur
1.
Zurück zum Zitat Lee AJ, Morgan CL, Morrissey M, et al. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005 Nov;22(11):1482–6. Lee AJ, Morgan CL, Morrissey M, et al. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005 Nov;22(11):1482–6.
2.
Zurück zum Zitat Prospective Studies C, Whitlock G, Lewington S, et al. Body-mass index and cause- specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England). 2009;373(9669):1083–96.CrossRef Prospective Studies C, Whitlock G, Lewington S, et al. Body-mass index and cause- specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England). 2009;373(9669):1083–96.CrossRef
3.
Zurück zum Zitat Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.CrossRef Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.CrossRef
4.
Zurück zum Zitat Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81:S46–51.CrossRef Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81:S46–51.CrossRef
5.
Zurück zum Zitat Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes, metabolic syndrome and obesity. Diabetes Metab Syndr Obes. 2010;3:285–95.CrossRef Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes, metabolic syndrome and obesity. Diabetes Metab Syndr Obes. 2010;3:285–95.CrossRef
6.
Zurück zum Zitat JPH. Wilding. Treatment strategies for obesity. Obes Rev. 2007;(Suppl. 1):137–44. JPH. Wilding. Treatment strategies for obesity. Obes Rev. 2007;(Suppl. 1):137–44.
7.
Zurück zum Zitat Hoerger TJ, Zhang P, Segel JE, et al. Cost- effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.CrossRef Hoerger TJ, Zhang P, Segel JE, et al. Cost- effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.CrossRef
8.
Zurück zum Zitat Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama. 2008;299(3):316–23.CrossRef Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama. 2008;299(3):316–23.CrossRef
9.
Zurück zum Zitat Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.CrossRef Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.CrossRef
10.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.CrossRef Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.CrossRef
11.
Zurück zum Zitat Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA surg. 2014;149(12):1323–9.CrossRef Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA surg. 2014;149(12):1323–9.CrossRef
12.
Zurück zum Zitat Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA surg. 2014;149(7):716–26.CrossRef Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA surg. 2014;149(7):716–26.CrossRef
13.
Zurück zum Zitat Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama. 2013;309(21):2240–9.CrossRef Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama. 2013;309(21):2240–9.CrossRef
15.
Zurück zum Zitat Frezza EE. Six steps to fast-track insurance approval for bariatric surgery. Obes Surg. 2006;16:659–63. [PubMed: 16687038]CrossRef Frezza EE. Six steps to fast-track insurance approval for bariatric surgery. Obes Surg. 2006;16:659–63. [PubMed: 16687038]CrossRef
18.
Zurück zum Zitat Tewksbury C, Williams NN, Dumon KR, et al. Preoperative medical weight management in bariatric surgery: a review and reconsideration. Obes Surg. 2017;27(1):208–14.CrossRef Tewksbury C, Williams NN, Dumon KR, et al. Preoperative medical weight management in bariatric surgery: a review and reconsideration. Obes Surg. 2017;27(1):208–14.CrossRef
19.
Zurück zum Zitat Jamal MK, DeMaria EJ, Johnson JM, et al. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2006;2(2):122–7.CrossRef Jamal MK, DeMaria EJ, Johnson JM, et al. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2006;2(2):122–7.CrossRef
20.
Zurück zum Zitat Ochner CN, Puma LM, Raevouri A, et al. Effectiveness of a prebariatric surgery insurance-required weight loss egiment and relation to postsurgical weight loss. Obesity. 2010;18(2):287–92.CrossRef Ochner CN, Puma LM, Raevouri A, et al. Effectiveness of a prebariatric surgery insurance-required weight loss egiment and relation to postsurgical weight loss. Obesity. 2010;18(2):287–92.CrossRef
21.
Zurück zum Zitat Kuwada TS, Richardson S, El Chaar M, et al. Insurance-mandated medical programs before bariatric surgery: do good things come to those who wait? Surg Obes Relat Dis. 2011;7(4):526–30.CrossRef Kuwada TS, Richardson S, El Chaar M, et al. Insurance-mandated medical programs before bariatric surgery: do good things come to those who wait? Surg Obes Relat Dis. 2011;7(4):526–30.CrossRef
22.
Zurück zum Zitat Horwitz D, Saunders JK, Ude-Welcome A, et al. Insurance- mandated medical weight management before bariatric surgery. Surg Obes Relat Dis. 2016;12(3):496–9.CrossRef Horwitz D, Saunders JK, Ude-Welcome A, et al. Insurance- mandated medical weight management before bariatric surgery. Surg Obes Relat Dis. 2016;12(3):496–9.CrossRef
25.
Zurück zum Zitat American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl. 1):S13–27.CrossRef American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl. 1):S13–27.CrossRef
27.
Zurück zum Zitat Venegas-Mariño M, Franco-Vélez A. Métodos diagnósticos en el síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev Fac Med. 2017;65(Sup):S91–5.CrossRef Venegas-Mariño M, Franco-Vélez A. Métodos diagnósticos en el síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev Fac Med. 2017;65(Sup):S91–5.CrossRef
28.
Zurück zum Zitat Brethauer SA, Julie Kim MD, Maher el Chaar MD, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506.CrossRef Brethauer SA, Julie Kim MD, Maher el Chaar MD, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506.CrossRef
29.
Zurück zum Zitat Harrison GG. Height-weight tables. Ann Intern Med. 1985;103:989–94.CrossRef Harrison GG. Height-weight tables. Ann Intern Med. 1985;103:989–94.CrossRef
30.
Zurück zum Zitat Love KM, Mehaffey JH, Safavian D, et al. Bariatric surgery insurance requirements independently predict surgery dropout. Surg Obes Relat Dis. 2017;13:871–6.CrossRef Love KM, Mehaffey JH, Safavian D, et al. Bariatric surgery insurance requirements independently predict surgery dropout. Surg Obes Relat Dis. 2017;13:871–6.CrossRef
31.
Zurück zum Zitat Cohen RV, Luque A, Junqueira S, et al. What 739 is the impact on the healthcare system if access to bariatric surgery is delayed? Surg Obes Relat Dis. 2017;13(9):1619–27.CrossRef Cohen RV, Luque A, Junqueira S, et al. What 739 is the impact on the healthcare system if access to bariatric surgery is delayed? Surg Obes Relat Dis. 2017;13(9):1619–27.CrossRef
32.
Zurück zum Zitat Al Harakeh AB, Burkhamer KJ, Kallies KJ, et al. Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–6.CrossRef Al Harakeh AB, Burkhamer KJ, Kallies KJ, et al. Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–6.CrossRef
34.
Zurück zum Zitat Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):141–5. discussion 5–6CrossRef Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):141–5. discussion 5–6CrossRef
35.
Zurück zum Zitat Cayci HM, Erdogdu UE, Karaman K, et al. Does weight gain during the operation wait time have an impact on weight loss after laparoscopic sleeve gastrectomy? Obes Surg. 2016;27(2):338–42.CrossRef Cayci HM, Erdogdu UE, Karaman K, et al. Does weight gain during the operation wait time have an impact on weight loss after laparoscopic sleeve gastrectomy? Obes Surg. 2016;27(2):338–42.CrossRef
36.
Zurück zum Zitat Eisenberg D, Duffy AJ, Bell RL. Does preoperative weight change predict postoperative weight loss after laparoscopic roux-en-Y gastric bypass in the short term? J Obes. 2010; Eisenberg D, Duffy AJ, Bell RL. Does preoperative weight change predict postoperative weight loss after laparoscopic roux-en-Y gastric bypass in the short term? J Obes. 2010;
37.
Zurück zum Zitat Still CD, Benotti P, Wood GC, et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg. 2007;142(10):994–8. discussion 9CrossRef Still CD, Benotti P, Wood GC, et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg. 2007;142(10):994–8. discussion 9CrossRef
38.
Zurück zum Zitat Schneider A et al. Postoperative outcomes in bariatric surgical patients participating in an insurance-mandated preoperative weight management program. Surg Obes Relat Dis. 14(5):623–30. Schneider A et al. Postoperative outcomes in bariatric surgical patients participating in an insurance-mandated preoperative weight management program. Surg Obes Relat Dis. 14(5):623–30.
39.
Zurück zum Zitat Fris RJ. Preoperative low-energy diet diminishes liver size. Obes Surg. 2004;14:1165–70.CrossRef Fris RJ. Preoperative low-energy diet diminishes liver size. Obes Surg. 2004;14:1165–70.CrossRef
40.
Zurück zum Zitat Diamant A, Cleghorn MC, Milner J, et al. Patient and operational factors affecting wait times in a bariatric surgery program in Toronto: a retrospective cohort study. CMAJ Open. 2015;3(3):E331–7.CrossRef Diamant A, Cleghorn MC, Milner J, et al. Patient and operational factors affecting wait times in a bariatric surgery program in Toronto: a retrospective cohort study. CMAJ Open. 2015;3(3):E331–7.CrossRef
Metadaten
Titel
Insurance-Related Delay in Access to Bariatric Surgery, Is It Helpful as Is Thought?
verfasst von
Emiliano Domeniconi
Carlos Martin Esquivel
Manuel Garcia
Matias Sosa
Pablo Arias
Fernando Martínez Lascano
José María Foscarini
Publikationsdatum
03.07.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04794-9

Weitere Artikel der Ausgabe 11/2020

Obesity Surgery 11/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.